Differential coupling of self-renewal signaling pathways in murine induced pluripotent stem cells

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Orlando, Luca ^a,b   Sanchez Ripoll, Yolanda ^a   Foster, James ^a   Bone, Heather ^a   Giachino, Claudia ^b   Welham, Melanie J ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEIN; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ARTICLE; CELL FATE; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CONTROLLED STUDY; COUPLING FACTOR; EMBRYONIC STEM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENOMIC INSTABILITY; KARYOTYPE; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL SHAPE; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EVALUATION; GENETICS; METABOLISM; NUCLEAR REPROGRAMMING; PHYSIOLOGY; TIME;

MURINAE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; CULTURE MEDIA; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; INDUCED PLURIPOTENT STEM CELLS; LEUKEMIA INHIBITORY FACTOR; MAP KINASE SIGNALING SYSTEM; MICE; NUCLEAR REPROGRAMMING; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84856088657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030234     Document Type: Article

References (53)

1. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
2. Stadtfeld M, Hochedlinger K, (2010) Induced pluripotency: history, mechanisms, and applications. Genes Dev 24: 2239-2263.
3. Okita K, Ichisaka T, Yamanaka S, (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
4. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, et al. (2009) Adult mice generated from induced pluripotent stem cells. Nature 461: 91-94.
5. Zhao XY, Li W, Lv Z, Liu L, Tong M, et al. (2009) iPS cells produce viable mice through tetraploid complementation. Nature 461: 86-90.
6. Kang L, Wang J, Zhang Y, Kou Z, Gao S, (2009) iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5: 135-138.
7. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
8. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, et al. (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3: 340-345.
9. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, et al. (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49-55.
10. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, et al. (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123.
11. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, et al. (2009) Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One 4: e7076.
12. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, et al. (2010) Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5: e8975.
13. Buecker C, Chen HH, Polo JM, Daheron L, Bu L, et al. (2010) A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 6: 535-546.
14. Di Stefano B, Buecker C, Ungaro F, Prigione A, Chen HH, et al. (2010) An ES-like pluripotent state in FGF-dependent murine iPS cells. PLoS One 5: e16092.
15. Li C, Yu H, Ma Y, Shi G, Jiang J, et al. (2009) Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor. PLoS One 4: e6724.
16. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, et al. (2011) Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 13: 541-549.
17. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, et al. (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 848-855.
18. Boeuf H, Hauss C, Graeve FD, Baran N, Kedinger C, (1997) Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J Cell Biol 138: 1207-1217.
19. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, et al. (2005) LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896.
20. Niwa H, Burdon T, Chambers I, Smith A, (1998) Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 12: 2048-2060.
21. Ying QL, Nichols J, Chambers I, Smith A, (2003) BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292.
22. Burdon T, Stracey C, Chambers I, Nichols J, Smith A, (1999) Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 210: 30-43.
23. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, et al. (2008) The ground state of embryonic stem cell self-renewal. Nature 453: 519-523.
24. Bone HK, Damiano T, Bartlett S, Perry A, Letchford J, et al. (2009) Involvement of glycogen synthase kinase-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides. Chemistry and Biology 16: 15-27.
25. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH, (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55-63.
26. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, et al. (2011) Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol 13: 838-845.
27. Jirmanova L, Afanassieff M, Gobert-Gosse S, Markossian S, Savatier P, (2002) Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21: 5515-5528.
28. Kingham E, Welham MJ, (2009) Distinct roles for class IA PI3K catalytic subunit isoforms in the regulation of murine embryonic stem cell behaviour. J Cell Sci 122.
29. Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K, et al. (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24: 6710-6718.
30. Takahashi K, Mitsui K, Yamanaka S, (2003) Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423: 541-545.
31. Paling NR, Wheadon H, Bone HK, Welham MJ, (2004) Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 279: 48063-48070.
32. Pritsker M, Ford NR, Jenq HT, Lemischka IR, (2006) Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc Natl Acad Sci U S A 103: 6946-6951.
33. Storm MP, Kumpfmueller B, Thompson B, Kolde R, Vilo J, et al. (2009) Characterisation of the PI3K-dependent transcriptome in murine ES cells: Identification of novel regulators of pluripotency. Stem Cells 27: 764-775.
34. Watanabe S, Umehara H, Murayama K, Okabe M, Kimura T, et al. (2006) Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25: 2697-2707.
35. Storm MP, Bone HK, Beck CG, Bourillot PY, Schreiber V, et al. (2007) Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J Biol Chem 282: 6265-6273.
36. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, et al. (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450: 1230-1234.
37. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, et al. (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369: 756-758.
38. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, et al. (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage committment. Development 134: 2895-2902.
39. Vlahos CJ, Matter WF, Hui KY, Brown RF, (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248.
40. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70.
41. Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, et al. (2011) A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 29: 279-286.
42. Kim K, Doi A, Wen B, Ng K, Zhao R, et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290.
43. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, et al. (2010) Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465: 175-181.
44. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, et al. (2011) Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144: 439-452.
45. Phanstiel DH, Brumbaugh J, Wenger CD, Tian S, Probasco MD, et al. (2011) Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods 8: 821-827.
46. Dreesen O, Brivanlou AH, (2007) Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3: 7-17.
47. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, et al. (2008) Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6: e253.
48. Shao L, Feng W, Sun Y, Bai H, Liu J, et al. (2009) Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 19: 296-306.
49. Wu G, Liu N, Rittelmeyer I, Sharma AD, Sgodda M, et al. (2011) Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells. PLoS Biol 9: e1001099.
50. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, et al. (2009) Role of the murine reprogramming factors in the induction of pluripotency. Cell 136: 364-377.
51. Bone HK, Welham MJ, (2007) Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis. Journal Cell Science 120: 1752-1762.
52. Paling NR, Welham MJ, (2005) Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis. Blood 105: 4290-4297.
53. Welham MJ, Duronio V, Leslie KB, Bowtell D, Schrader JW, (1994) Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. J Biol Chem 269: 21165-21176.